Filtered By:
Infectious Disease: Common Cold
Countries: Japan Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 7 results found since Jan 2013.
Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia
ConclusionMirogabalin was generally safe, well tolerated, and effective for treatment of CNeP in this long-term study.Trial registrationClinicalTrials.gov identifier, NCT03901352.
Source: Pain and Therapy - April 28, 2023 Category: Anesthesiology Source Type: research
Prevalence of COVID-19 Mimics in the Emergency Department
Conclusion Several potentially fatal diseases remain masked among the wave of COVID-19 mimics. It is imperative that a thorough differential diagnostic panel be considered prior to the rendering of a COVID-19 diagnosis.PMID:34334560 | DOI:10.2169/internalmedicine.6434-20
Source: Internal Medicine - August 2, 2021 Category: Internal Medicine Authors: Satoshi Kurihara Mikio Nakajima Richard H Kaszynski Yasuhiro Yamamoto Koichiro Santo Ryo Takane Hayato Tokuno Ayaka Ishihata Hitoshi Ando Maki Miwa Shoichiro Hamada Tomotsugu Nakano Masamitsu Shirokawa Hideaki Goto Yoshihiro Yamaguchi Source Type: research
